A systems-approach to NAD+ restoration.

Nichola Conlon1, Dianne Ford2

  • 1Nuchido Ltd. Dissington Hall, Dalton, Northumberland NE18 0AD, United Kingdom.

Biochemical Pharmacology
|February 8, 2022
PubMed
Summary

NAD+ decline is linked to aging. Targeting multiple NAD+ pathways, rather than single targets, may offer a more reliable approach to slow aging.